Net income GlaxoSmithKline plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income GlaxoSmithKline plc is 1 395 000 000 $ Current assets GlaxoSmithKline plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets GlaxoSmithKline plc is 17 566 000 000 $ Total assets GlaxoSmithKline plc refers to the total amount of assets owned by a person or entity. Total assets GlaxoSmithKline plc is 77 011 000 000 $
|
30/06/2021
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
|
5 538 000 000 $ |
4 980 000 000 $ |
5 777 000 000 $ |
5 928 000 000 $ |
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
|
2 554 000 000 $ |
2 438 000 000 $ |
2 962 000 000 $ |
2 718 000 000 $ |
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
|
8 092 000 000 $ |
7 418 000 000 $ |
8 739 000 000 $ |
8 646 000 000 $ |
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
|
- |
- |
- |
- |
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
|
1 675 000 000 $ |
1 609 000 000 $ |
1 991 000 000 $ |
2 458 000 000 $ |
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
|
1 395 000 000 $ |
1 073 000 000 $ |
677 000 000 $ |
1 244 000 000 $ |
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
|
1 222 000 000 $ |
1 103 000 000 $ |
1 322 000 000 $ |
1 066 000 000 $ |
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
|
6 417 000 000 $ |
5 809 000 000 $ |
6 748 000 000 $ |
6 188 000 000 $ |
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
|
17 566 000 000 $ |
18 524 000 000 $ |
20 247 000 000 $ |
19 881 000 000 $ |
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
|
77 011 000 000 $ |
78 079 000 000 $ |
80 431 000 000 $ |
80 927 000 000 $ |
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
|
3 503 000 000 $ |
4 757 000 000 $ |
6 292 000 000 $ |
4 283 000 000 $ |
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
|
- |
- |
- |
- |
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
|
- |
- |
- |
- |
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
|
- |
- |
- |
- |
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
|
- |
- |
- |
- |
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
|
15 377 000 000 $ |
14 865 000 000 $ |
14 587 000 000 $ |
14 286 000 000 $ |
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
|
- |
- |
- |
- |